Nigel S Moore

Identification of Selective Dual ROCK1 and ROCK2 Inhibitors Using Structure-Based Drug Design.

Ana L. Aguirre, A. Hobson, K. Sarris, 2018, Journal of medicinal chemistry.

Enabling structure-based drug design of Tyk2 through co-crystallization with a stabilizing aminoindazole inhibitor

R. Dixon, D. Borhani, R. Talanian, 2012, BMC Structural Biology.

Discovery of A-971432, An Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonist for the Potential Treatment of Neurodegenerative Disorders.

Ana L. Aguirre, A. Hobson, K. Sarris, 2015, Journal of medicinal chemistry.

Synthesis and activity of N-cyanoguanidine-piperazine P2X7 antagonists.

E. Tarcsa, M. Namovic, Kevin R. Woller, 2008, Bioorganic & medicinal chemistry letters.